Professor Stephen R Durham

Publications


Journals

  • Dreborg S; Lee TH; Kay AB; Durham SR. (1 Jan 2012). Immunotherapy Is Allergen-Specific: A Double-Blind Trial of Mite or Timothy Extract in Mite and Grass Dual-Allergic Patients. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 158:63-70. Author weblink DOI.
  • Durham SR; Emminger W; Kapp A; de Monchy JG; Rak S; Scadding GK; Wurtzen PA; Andersen JS; et alTholstrup B; Riis B; Dahl R. (Mar 2012). SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol. 129:717-725.e5. DOI.
  • Shamji MH; Ljørring C; Francis JN; Calderon MA; Larché M; Kimber I; Frew AJ; Ipsen H; et alLund K; Würtzen PA; Durham SR. (Feb 2012). Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy. 67:217-226. DOI.
  • Bousquet J; Heinzerling L; Bachert C; Papadopoulos NG; Bousquet PJ; Burney PG; Canonica GW; Carlsen KH; et alCox L; Haahtela T; Lodrup Carlsen KC; Price D; Samolinski B; Simons FE; Wickman M; Annesi-Maesano I; Baena-Cagnani CE; Bergmann KC; Bindslev-Jensen C; Casale TB; Chiriac A; Cruz AA; Dubakiene R; Durham SR; Fokkens WJ; Gerth-van-Wijk R; Kalayci O; Kowalski ML; Mari A; Mullol J; Nazamova-Baranova L; O'Hehir RE; Ohta K; Panzner P; Passalacqua G; Ring J; Rogala B; Romano A; Ryan D; Schmid-Grendelmeier P; Todo-Bom A; Valenta R; Woehrl S; Yusuf OM; Zuberbier T; Demoly P; Global Allergy and Asthma European Network; Allergic Rhinitis and its Impact on Asthma. (Jan 2012). Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 67:18-24. DOI.
  • Eifan AO; Shamji MH; Durham SR. (Dec 2011). Long-term clinical and immunological effects of allergen immunotherapy. Curr Opin Allergy Clin Immunol. 11:586-593. DOI.
  • Krishna MT; Ewan PW; Diwakar L; Durham SR; Frew AJ; Leech SC; Nasser SM; British Society for Allergy and Clinical Immunology. (Sep 2011). Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy. 41:1201-1220. DOI.
  • Walker SM; Durham SR; Till SJ; Roberts G; Corrigan CJ; Leech SC; Krishna MT; Rajakulasingham RK; et alWilliams A; Chantrell J; Dixon L; Frew AJ; Nasser SM; British Society for Allergy and Clinical Immunology. (Sep 2011). Immunotherapy for allergic rhinitis. Clin Exp Allergy. 41:1177-1200. DOI.
  • Shamji MH; Durham SR. (1 Sep 2011). Mechanisms of immunotherapy to aeroallergens. CLINICAL AND EXPERIMENTAL ALLERGY. 41:1235-1246. Author weblink DOI.
  • Calderon MA; Penagos M; Sheikh A; Canonica GW; Durham SR. (Sep 2011). Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis. Clin Exp Allergy. 41:1263-1272. DOI.
  • Blaiss M; Nelson HS; Durham SR; Dahl R; Bufe A. (1 Aug 2011). Sublingual immunotherapy: Allergen specific or placebo effect? Reply. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 128:430-432. DOI.
  • Shamji MH; Durham SR. (Sep 2011). Mechanisms of immunotherapy to aeroallergens. Clin Exp Allergy. 41:1235-1246. DOI.
  • Durham SR. (1 Jul 2011). Sustained effects of grass pollen AIT. ALLERGY. 66:50-52. DOI.
  • Calderón MA; Larenas D; Kleine-Tebbe J; Jacobsen L; Passalacqua G; Eng PA; Varga EM; Valovirta E; et alMoreno C; Malling HJ; Alvarez-Cuesta E; Durham S; Demoly P. (Oct 2011). European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'. Allergy. 66:1345-1359. DOI.
  • Scadding G; Durham SR. (May 2011). Mechanisms of sublingual immunotherapy. Immunol Allergy Clin North Am. 31:191-viii. DOI.
  • Shamji MH; James LK; Durham SR. (May 2011). Serum immunologic markers for monitoring allergen-specific immunotherapy. Immunol Allergy Clin North Am. 31:311-x. DOI.
  • Skypala IJ; Calderon MA; Leeds AR; Emery P; Till SJ; Durham SR. (Jul 2011). Development and validation of a structured questionnaire for the diagnosis of oral allergy syndrome in subjects with seasonal allergic rhinitis during the UK birch pollen season. Clin Exp Allergy. 41:1001-1011. DOI.
  • Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; et alCarlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T. (Jun 2011). How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy. 66:765-774. DOI.
  • Radulovic S; Wilson D; Calderon M; Durham S. (Jun 2011). Systematic reviews of sublingual immunotherapy (SLIT). Allergy. 66:740-752. DOI.
  • James LK; Shamji MH; Walker SM; Wilson DR; Wachholz PA; Francis JN; Jacobson MR; Kimber I; et alTill SJ; Durham SR. (Feb 2011). Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol. 127:509-516.e1-5. DOI.
  • Durham SR; Leung DY. (Jan 2011). One hundred years of allergen immunotherapy: time to ring the changes. J Allergy Clin Immunol. 127:3-7. DOI.
  • Calderon MA; Penagos M; Sheikh A; Canonica GW; Durham S. (2011). Sublingual immunotherapy for treating allergic conjunctivitis. Cochrane Database Syst Rev. CD007685. DOI.
  • Bousquet PJ; Calderon MA; Demoly P; Larenas D; Passalacqua G; Bachert C; Brozek J; Canonica GW; et alCasale T; Fonseca J; Dahl R; Durham SR; Merk H; Worm M; Wahn U; Zuberbier T; Schuenemann HJ; Bousquet J. (1 Jan 2011). The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA(2)LEN) article. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 127:49-U511. DOI.
  • Calderón MA; Casale TB; Togias A; Bousquet J; Durham SR; Demoly P. (Jan 2011). Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol. 127:30-38. DOI.
  • Bousquet J; Schunemann HJ; Zuberbier T; Bachert C; Baena-Cagnani CE; Bousquet PJ; Brozek J; Canonica GW; et alCasale TB; Demoly P; Gerth van Wijk R; Ohta K; Bateman ED; Calderon M; Cruz AA; Dolen WK; Haughney J; Lockey RF; Lotvall J; O'Byrne P; Spranger O; Togias A; Bonini S; Boulet LP; Camargos P; Carlsen KH; Chavannes NH; Delgado L; Durham SR; Fokkens WJ; Fonseca J; Haahtela T; Kalayci O; Kowalski ML; Larenas-Linnemann D; Li J; Mohammad Y; Mullol J; Naclerio R; O'Hehir RE; Papadopoulos N; Passalacqua G; Rabe KF; Pawankar R; Ryan D; Samolinski B; Simons FER; Valovirta E; Yorgancioglu A; Yusuf OM; Agache I; Ait-Khaled N; Annesi-Maesano I; Beghe B; Ben Kheder A; Blaiss MS; Boakye DA; Bouchard J; Burney PG; Busse WW; Chan-Yeung M; Chen Y; Chuchalin AG; Costa DJ; Custovic A; Dahl R; Denburg J; Douagui H; Emuzyte R; Grouse L; Humbert M; Jackson C; Johnston SL; Kaliner MA; Keith PK; Kim YY; Klossek JM; Kuna P; Le LT; Lemiere C; Lipworth B; Mahboub B; Malo JL; Marshall GD; Mavale-Manuel S; Meltzer EO; Morais-Almeida M; Motala C; Naspitz C; Nekam K; Niggemann B; Nizankowska-Mogilnicka E; Okamoto Y; Orru MP; Ouedraogo S; Palkonen S; Popov TA; Price D; Rosado-Pinto J; Scadding GK; Sooronbaev TM; Stoloff SW; Toskala E; van Cauwenberge P; Vandenplas O; van Weel C; Viegi G; Virchow JC; Wang DY; Wickman M; Williams D; Yawn BP; Zar HJ; Zernotti M; Zhong N. (1 Oct 2010). Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper. ALLERGY. 65:1212-1221. DOI.
  • Pree I; Shamji MH; Kimber I; Valenta R; Durham SR; Niederberger V. (1 Sep 2010). Inhibition of CD23-dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules. CLINICAL AND EXPERIMENTAL ALLERGY. 40:1346-1352. DOI.
  • Durham SR; Scadding GW. (Sep 2010). Response by stephen R. Durham and g.w. Scadding. Clin Exp Allergy. 40:1432. DOI.
  • Durham SR; Scadding GW. (1 Sep 2010). Sublingual immunotherapy affects transforming growth factor-beta and nasal eosinophils Response. CLINICAL AND EXPERIMENTAL ALLERGY. 40:1432-1432.
  • Durham SR; Birk AO; Andersen JS. (Jan 2011). Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials. Allergy. 66:120-123. DOI.
  • Frolund L; Durham SR; Calderon M; Emminger W; Andersen JS; Rask P; Dahl R. (1 Jun 2010). Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life. ALLERGY. 65:753-757. Author weblink DOI.
  • Scadding GW; Shamji MH; Jacobson MR; Lee DI; Wilson D; Lima MT; Pitkin L; Pilette C; et alNouri-Aria K; Durham SR. (Apr 2010). Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy. 40:598-606. DOI.
  • Banfield G; Watanabe H; Scadding G; Jacobson MR; Till SJ; Hall DA; Robinson DS; Lloyd CM; et alNouri-Aria KT; Durham SR. (Sep 2010). CC chemokine receptor 4 (CCR4) in human allergen-induced late nasal responses. Allergy. 65:1126-1133. DOI.
  • Durham SR; Emminger W; Kapp A; Colombo G; de Monchy JGR; Rak S; Scadding GK; Andersen JS; et alRiis B; Dahl R. (1 Jan 2010). Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 125:131-138. DOI.
  • Radulovic S; Calderon MA; Wilson D; Durham S. (1 Jan 2010). Sublingual immunotherapy for allergic rhinitis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS. . Author weblink DOI.
  • Eyerich S; Eyerich K; Pennino D; Carbone T; Nasorri F; Pallotta S; Cianfarani F; Odorisio T; et alTraidl-Hoffmann C; Behrendt H; Durham SR; Schmidt-Weber CB; Cavani A. (1 Dec 2009). Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. JOURNAL OF CLINICAL INVESTIGATION. 119:3573-3585. Author weblink DOI.
  • Bousquet PJ; Brozek J; Bachert C; Bieber T; Bonini S; Burney P; Calderon M; Canonica GW; et alCompalati E; Daures JP; Delgado L; Demoly P; Dahl R; Durham SR; Kowalski ML; Malling HJ; Merk H; Papadopoulos N; Passalacqua G; Simon HU; Worms M; Wahn U; Zuberbier T; Schuenemann HJ; Bousquet J. (1 Dec 2009). The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper. ALLERGY. 64:1737-1745. Author weblink DOI.
  • Bousquet P-J; Burbach G; Heinzerling LM; Edenharter G; Bachert C; Bindslev-Jensen C; Bonini S; Bousquet-Rouanet L; et alDemoly P; Bresciani M; Bruno A; Gjomarkaj M; Canonica GW; Darsow U; Durham S; Fokkens WJ; Giavi S; Gramiccioni C; Papadopoulos NG; Haahtela T; Kowalski ML; Magyar P; Murakozi G; Orosz M; Roehnelt C; Stingl G; Todo-Bom A; von Mutius E; Wiesner A; Woehrl S; Bousquet J; Zuberbier T. (1 Nov 2009). GA2LEN skin test study III: Minimum battery of test inhalent allergens needed in epidemiological studies in patients. ALLERGY. 64:1656-1662. Author weblink DOI.
  • Macedo P; Saleh H; Torrego A; Arbery J; MacKay I; Durham SR; Chung KF. (1 Nov 2009). Postnasal drip and chronic cough: An open interventional study. RESPIRATORY MEDICINE. 103:1700-1705. Author weblink DOI.
  • James LK; Durham SR. (1 Nov 2009). Rhinitis with negative skin tests and absent serum allergen-specific IgE: More evidence for local IgE?. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 124:1012-1013. Author weblink DOI.
  • Anderson AE; Mackerness KJ; Aizen M; Carr VA; Nguyen D; Du Pre F; Durham SR; Robinson DS. (1 Nov 2009). Seasonal changes in suppressive capacity of CD4+ CD25+ T cells from patients with hayfever are allergen-specific and may result in part from expansion of effector T cells among the CD25+ population. CLINICAL AND EXPERIMENTAL ALLERGY. 39:1693-1699. Author weblink DOI.
  • Heinzerling LM; Burbach GJ; Edenharter G; Bachert C; Bindslev-Jensen C; Bonini S; Bousquet J; Bousquet-Rouanet L; et alBousquet PJ; Bresciani M; Bruno A; Burney P; Canonica GW; Darsow U; Demoly P; Durham S; Fokkens WJ; Giavi S; Gjomarkaj M; Gramiccioni C; Haahtela T; Kowalski ML; Magyar P; Murakozi G; Orosz M; Papadopoulos NG; Rohnelt C; Stingl G; Todo-Bom A; von Mutius E; Wiesner A; Wohrl S; Zuberbier T. (1 Oct 2009). GA2LEN skin test study I: GA superset of LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. ALLERGY. 64:1498-1506. Author weblink DOI.
  • Burbach GJ; Heinzerling LM; Edenharter G; Bachert C; Bindslev-Jensen C; Bonini S; Bousquet J; Bousquet-Rouanet L; et alBousquet PJ; Bresciani M; Bruno A; Canonica GW; Darsow U; Demoly P; Durham S; Fokkens WJ; Giavi S; Gjomarkaj M; Gramiccioni C; Haahtela T; Kowalski ML; Magyar P; Murakozi G; Orosz M; Papadopoulos NG; Rohnelt C; Stingl G; Todo-Bom A; von Mutius E; Wiesner A; Wohrl S; Zuberbier T. (1 Oct 2009). GA2LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. ALLERGY. 64:1507-1515. Author weblink DOI.
  • Eyerich K; Foerster S; Pennino D; Carbone T; Cianferani F; Odorisio T; Traidl-Hoffmann C; Durham S; et alSchmidt-Weber C; Cavani A. (1 Sep 2009). Th22 cells represent a distinct human T lymphocyte subset of tissue-signaling leukocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 129:S2-S2. Author weblink.
  • Varga E-M; Francis JN; Zach MS; Klunker S; Aberer W; Durham SR. (1 Sep 2009). Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children. CLINICAL AND EXPERIMENTAL ALLERGY. 39:1353-1357. Author weblink DOI.
  • Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; et alHenry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW. (1 Aug 2009). Clinical efficacy and immune regulation with peanut oral immunotherapy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 124:292-300. DOI.
  • Mirakian R; Ewan PW; Durham SR; Youlten LJF; Dugue P; Friedmann PS; English JS; Huber PAJ; et alNasser SM. (1 Jan 2009). BSACI guidelines for the management of drug allergy. CLINICAL AND EXPERIMENTAL ALLERGY. 39:43-61. Author weblink DOI.
  • Scadding G; Durham S. (May 2009). Mechanisms of sublingual immunotherapy. J Asthma. 46:322-334. DOI.
  • Durham SR. (2009). SQ-standardised grass tablet sublingual immunotherapy: persistent clinical benefit and progressive immunological changes during three years treatment. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 96:121-127.
  • Durham SR. (Dec 2008). Mechanisms of immunotherapy. Drugs Today (Barc). 44 Suppl B:93-94.
  • Nouri-Aria KT; Durham SR. (Dec 2008). Regulatory T cells and allergic disease. Inflamm Allergy Drug Targets. 7:237-252.
  • Durham SR. (Dec 2008). Sublingual immunotherapy: what have we learnt from the 'big trials'?. Curr Opin Allergy Clin Immunol. 8:577-584. DOI.
  • Chapman MD; Ferreira F; Villalba M; Cromwell O; Bryan D; Becker W-M; Fernandez-Rivas M; Durham S; et alVieths S; van Ree R. (1 Nov 2008). The European Union CREATE Project: A model for international standardization of allergy diagnostics and vaccines. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 122:882-889. Author weblink DOI.
  • Bousquet J; Fokkens W; Burney P; Durham SR; Bachert C; Akdis CA; Canonica GW; Dahlen S-E; et alZuberbier T; Bieber T; Bonini S; Bousquet PJ; Brozek JL; Cardell L-O; Crameri R; Custovic A; Demoly P; van Wijk RG; Gjomarkaj M; Holland C; Howarth P; Humbert M; Johnston SL; Kauffmann F; Kowalski ML; Lambrecht B; Lehmann S; Leynaert B; Lodrup-Carlsen K; Mullol J; Niggemann B; Nizankowska-Mogilnicka E; Papadopoulos N; Passalacqua G; Schuenemann HJ; Simon H-U; Todo-Bom A; Toskala E; Valenta R; Wickman M; Zock JP. (1 Jul 2008). Important research questions in allergy and related diseases: nonallergic rhinitis: a GA(2)LEN paper. ALLERGY. 63:842-853. Author weblink DOI.
  • Alvarez-Cuesta E; Bousquet J; Canonica WG; Durham S; Malling H-J; Passalacqua G; Valovirta E. (1 Jul 2008). Reply to the letter by Dr Fleming Madsen (EAACI 'Standards for practical allergen-specific immunotherapy'). ALLERGY. 63:939-940. Author weblink DOI.
  • James LK; Durham SR. (Jul 2008). Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy. 38:1074-1088. DOI.
  • Francis JN; Sabroe I; Lloyd CM; Durham SR; Till SJ. (Jun 2008). Elevated CCR6+ CD4+ T lymphocytes in tissue compared with blood and induction of CCL20 during the asthmatic late response. Clin Exp Immunol. 152:440-447. DOI.
  • Radulovic S; Jacobson MR; Durham SR; Nouri-Aria KT. (Jun 2008). Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol. 121:1467-1472.e1. DOI.
  • Francis JN; James LK; Paraskevopoulos G; Wong C; Calderon MA; Durham SR; Till SJ. (1 May 2008). Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 121:1120-1125. Author weblink DOI.
  • Bousquet J; Khaltaev N; Cruz AA; Denburg J; Fokkens WJ; Togias A; Zuberbier T; Baena-Cagnani CE; et alCanonica GW; van Weel C; Agache I; Ait-Khaled N; Bachert C; Blaiss MS; Bonini S; Boulet L-P; Bousquet P-J; Camargos P; Carlsen K-H; Chen Y; Custovic A; Dahl R; Demoly P; Douagui H; Durham SR; van Wijk RG; Kalayci O; Kaliner MA; Kim Y-Y; Kowalski ML; Kuna P; Le LTT; Lemiere C; Li J; Lockey RF; Mavale-Manuel S; Meltzer EO; Mohammad Y; Mullol J; Naclerio R; Hehir REO; Ohta K; Ouedraogo S; Palkonen S; Papadopoulos N; Passalacqua G; Pawankar R; Popov TA; Rabe KF; Rosado-Pinto J; Scadding GK; Simons FER; Toskala E; Valovirta E; van Cauwenberge P; Wang D-Y; Wickman M; Yawn BP; Yorgancioglu A; Yusuf OM; Zar H; Annesi-Maesano I; Bateman ED; Ben Kheder A; Boakye DA; Bouchard J; Burney P; Busse WW; Chan-Yeung M; Chavannes NH; Chuchalin A; Dolen WK; Emuzyte R; Grouse L; Humbert M; Jackson C; Johnston SL; Keith PK; Kemp JP; Klossek J-M; Larenas-Linnemann D; Lipworth B; Malo J-L; Marshall GD; Naspitz C; Nekam K; Niggemann B; Nizankowska-Mogilnicka E; Okamoto Y; Orru MP; Potter P; Price D; Stoloff SW; Vandenplas O; Viegi G; Williams D. (1 Jan 2008). Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). ALLERGY. 63:8-+. Author weblink DOI.
  • Van Ree R; Chapman MD; Ferreira F; Vieths S; Bryan D; Cromwell O; Villalba M; Durham SR; et alBecker WM; Aalbers M; Andre C; Barber D; Bahima AC; Custovic A; Didierlaurent A; Dolman C; Dorpema JW; Di Felice G; Eberhardt F; Fernandez Caldas E; Fernandez Rivas M; Fiebig H; Focke M; Foetisch K; Gadermaier G; Das RG; Gonzalez Mancebo E; Himly M; Kinaciyan T; Knulst AC; Kroon AM; Lepp U; Marco FM; Mari A; Moingeon P; Monsalve R; Neubauer A; Notten S; Heer PO; Pauli G; Pini C; Purohit A; Quiralte J; Rak S; Raulf-Heimsoth M; SanMiguel Moncin MM; Simpson B; Tsay A; Vailes L; Wallner M; Weber B. (1 Mar 2008). The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification. ALLERGY. 63:310-326. Author weblink DOI.
  • Scadding GK; Durham SR; Mirakian R; Jones NS; Drake-Lee AB; Ryan D; Dixon TA; Huber PAJ; et alNasser SM. (1 Feb 2008). BSACI guidelines for the management of rhinosinusitis and nasal polyposis. CLINICAL AND EXPERIMENTAL ALLERGY. 38:260-275. Author weblink DOI.
  • Nouri-Aria KT; Jacobson MR; Furukido K; Lee D; Banfield G; Durham SR. (1 Feb 2008). Increases in plasmacytoid but not Myeloid Dendritic Cells (DCs) parallel the time course of allergen-induced cutaneous late responses. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 121:S11-S11. Author weblink DOI.
  • Dahl R; Kapp A; Colombo G; De Monchy JGR; Rak S; Emminger W; Riis B; Gronager PM; et alDurham SR. (1 Feb 2008). Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 121:512-518. Author weblink DOI.
  • Till SJ; Durham SR. (2008). Immunologic responses to subcutaneous allergen immunotherapy. Clin Allergy Immunol. 21:59-70.
  • Calderón MA; Penagos M; Durham SR. (2008). Sublingual immunotherapy for allergic Rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases. Clin Allergy Immunol. 21:359-375.
  • Powell RJ; Frew AJ; Corrigan CJ; Durham SR. (1 Nov 2007). Effect of grass pollen immunotherapy with Alutard SQ((R)) on quality of life in seasonal allergic rhinoconjunctivitis. ALLERGY. 62:1335-1338. Author weblink DOI.
  • Saleh HA; Durham SR. (8 Sep 2007). Perennial rhinitis. BRITISH MEDICAL JOURNAL. 335:502-507. Author weblink DOI.
  • Klunker S; Saggar LR; Seyfert-Margolis V; Asare AL; Casale TB; Durham SR; Francis JN; Immune Tolerance Network Group. (Sep 2007). Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding. J Allergy Clin Immunol. 120:688-695. DOI.
  • Durham SR; Riis B. (Aug 2007). Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy. 62:954-957. DOI.
  • Calderon MA; Birk AO; Andersen JS; Durham SR. (Aug 2007). Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy. Allergy. 62:958-961. DOI.
  • Van Cauwenberge P; Watelet J-B; Van Zele T; Wang D-Y; Toskala E; Durham S; Fokkens W; Lau S; et alLeynaert B; Wickman M; Salapatas M; Burney P; Mullol J. (1 Jun 2007). Does rhinitis lead to asthma?. RHINOLOGY. 45:112-121. Author weblink.
  • Passalacqua G; Durham SR. (1 Apr 2007). Allergic rhinitis and its impact on asthma update: Allergen immunotherapy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 119:881-891. Author weblink DOI.
  • Pilette C; Nouri-Aria KT; Jacobson MR; Wilcock LK; Detry B; Walker SM; Francis JN; Durham SR. (1 Apr 2007). Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression. J Immunol. 178:4658-4666.
  • Durham SR. (Apr 2007). Tradition and innovation: finding the right balance. J Allergy Clin Immunol. 119:792-795. DOI.
  • Jones M; Floyd A; Nouri-Aria KT; Jacobson MR; Durham SR; Taylor AN; Cullinan P. (1 Mar 2007). Evidence for allergic reactions in isocyanate asthma - Reply. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 119:758-758. Author weblink DOI.
  • Durham S. (1 Jan 1998). The many faces of asthma - Proceedings from a symposium held at the annual meeting of the European Academy of Allergology and Clinical Immunology in Rhodes, Greece, June 1997 - Introduction. ALLERGY. 53:5-6. Author weblink.
  • Durham SR. (Feb 2007). Reply. J Allergy Clin Immunol. 119:515-517. Publisher weblink DOI.
  • Calderon MA; Alves B; Jacobson M; Hurwitz B; Sheikh A; Durham S. (2007). Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev. CD001936. DOI.
  • Takhar P; Corrigan CJ; Smurthwaite L; O'Connor BJ; Durham SR; Lee TH; Gould HJ. (1 Jan 2007). Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 119:213-218. Author weblink DOI.
  • Klimek L; Bachert C; Canonica GW; Durham SR; Mullol J; Van Cauwenberge PB; Van Hammee G. (1 Jan 2007). Long-term treatment of persistent allergic rhinitis with levocetirizine. ALLERGY & CLINICAL IMMUNOLOGY INTERNATIONAL-JOURNAL OF THE WORLD ALLERGY ORGANIZATION. 19:4-10. Author weblink DOI.
  • Francis JN; Lloyd CM; Sabroe I; Durham SR; Till SJ. (Jan 2007). T lymphocytes expressing CCR3 are increased in allergic rhinitis compared with non-allergic controls and following allergen immunotherapy. Allergy. 62:59-65. DOI.
  • Shamji MH; Wilcock LK; Wachholz PA; Dearman RJ; Kimber I; Wurtzen PA; Larche M; Durham SR; et alFrancis JN. (20 Dec 2006). The IgE-facilitated allergen binding (FAB) assay: Validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. JOURNAL OF IMMUNOLOGICAL METHODS. 317:71-79. Author weblink DOI.
  • Bonini S; Ansotegui IJ; Durham S; Frew AJ; Lotvall J; Nekam K; Popov T; Dahl R; et alGayraud J; van Wijk RG; Kontou-Fili K; Kowalski M; Todo-Bon A; Wahn U. (1 Oct 2006). Allergy and clinical immunology services in Europe. ALLERGY. 61:1191-1196. Author weblink DOI.
  • Gould HJ; Takhar P; Harries HE; Durham SR; Corrigan CJ. (1 Oct 2006). Germinal-centre reactions in allergic inflammation. TRENDS IN IMMUNOLOGY. 27:446-452. Author weblink DOI.
  • Canonica GW; Bousquet J; Van Hammee G; Bachert C; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB. (1 Oct 2006). Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. RESPIRATORY MEDICINE. 100:1706-1715. Author weblink DOI.
  • Bousquet J; van Cauwenberge P; Khaled NA; Bachert C; Baena-Cagnani CE; Bouchard J; Bunnag C; Canonica GW; et alCarlsen K-H; Chen Y-Z; Cruz AA; Custovic A; Demoly P; Dubakiene R; Durham S; Fokkens W; Howarth P; Kemp J; Kowalski ML; Kvedariene V; Lipworth B; Lockey R; Lund V; Mavale-Manuel S; Meltzer EO; Mullol J; Naclerio R; Nekam K; Ohta K; Papadopoulos N; Passalacqua G; Pawankar R; Popov T; Potter P; Price D; Scadding G; Simons FER; Spicak V; Valovirta E; Wang D-Y; Yawn B; Yusuf O. (1 Sep 2006). Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA(2)LEN). ALLERGY. 61:1086-1096. Author weblink DOI.
  • Dahl R; Kapp A; Colombo G; deMonchy JGR; Rak S; Emminger W; Rivas MF; Ribel M; et alDurham SR. (1 Aug 2006). Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 118:434-440. Author weblink DOI.
  • Durham SR. (Jul 2006). Allergen immunotherapy (desensitisation) for allergic diseases. Clin Med. 6:348-351.
  • Wilcock LK; Francis JN; Durham SR. (1 May 2006). IgE-facilitated antigen presentation: Role in allergy and the influence of allergen immunotherapy. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. 26:333-+. Author weblink DOI.
  • Erin EM; Leaker BR; Zacharasiewicz A; Higgins LA; Nicholson GC; Boyce MJ; de Boer P; Jones RC; et alDurham SR; Barnes PJ; Hansel TT. (1 Apr 2006). Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses. CLINICAL AND EXPERIMENTAL ALLERGY. 36:458-464. Author weblink DOI.
  • Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S. (Apr 2006). Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 117:802-809. DOI.
  • Jones MG; Floyd A; Nouri-Aria KT; Jacobson MR; Durham SR; Taylor AN; Cullinan P. (Mar 2006). Is occupational asthma to diisocyanates a non-IgE-mediated disease?. J Allergy Clin Immunol. 117:663-669. DOI.
  • Frew AJ; Powell RJ; Corrigan CJ; Durham SR. (1 Feb 2006). Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 117:319-325. Author weblink DOI.
  • Erin EM; Leaker BR; Zacharasiewicz AS; Higgins LA; Williams TJ; Boyce MJ; de Boer P; Durham SR; et alBarnes PJ; Hansel TT. (Dec 2005). Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge. Allergy. 60:1524-1529. DOI.
  • Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; et alBarnes PJ; Hansel TT. (1 Dec 2005). Topical corticosteroid inhibits interleukin-4,-5 and-13 in nasal secretions following allergen challenge. CLINICAL AND EXPERIMENTAL ALLERGY. 35:1608-1614. Author weblink DOI.
  • Coker HA; Harries HE; Banfield GK; Carr VA; Durham SR; Chevretton E; Hobby P; Sutton BJ; et alGould HJ. (Aug 2005). Biased use of VH5 IgE-positive B cells in the nasal mucosa in allergic rhinitis. J Allergy Clin Immunol. 116:445-452. DOI.
  • Erin EM; Neighbour H; Tan AJ; Kon OM; Durham SR; Hansel TT. (1 Aug 2005). Nasal testing for novel anti-inflammatory agents. CLINICAL AND EXPERIMENTAL ALLERGY. 35:981-985. Author weblink DOI.
  • Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR. (Jul 2005). IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. J Allergy Clin Immunol. 116:73-79. DOI.
  • Puggioni F; Durham SR; Francis JN. (May 2005). Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses. Allergy. 60:678-684. DOI.
  • Takhar P; Smurthwaite L; Coker HA; Fear DJ; Banfield GK; Carr VA; Durham SR; Gould HJ. (15 Apr 2005). Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol. 174:5024-5032.
  • Bauchau V; Durham SR. (Mar 2005). Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy. 60:350-353. DOI.
  • Rowe-Jones JM; Medcalf M; Durham SR; Richards DH; Mackay IS. (1 Mar 2005). Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. RHINOLOGY. 43:2-10. Author weblink.
  • Howarth PH; Persson CG; Meltzer EO; Jacobson MR; Durham SR; Silkoff PE. (Mar 2005). Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol. 115:S414-S441. DOI.
  • Netuveli G; Hurwitz B; Levy M; Fletcher M; Barnes G; Durham SR; Sheikh A. (22 Jan 2005). Ethnic variations in UK asthma frequency, morbidity, and health-service use: a systematic review and meta-analysis. Lancet. 365:312-317. DOI.
  • Wilson DR; Lima MT; Durham SR. (Jan 2005). Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy. 60:4-12. DOI.
  • Francis JN; Durham SR. (Dec 2004). Adjuvants for allergen immunotherapy: experimental results and clinical perspectives. Curr Opin Allergy Clin Immunol. 4:543-548.
  • Meltzer EO; Hamilos DL; Hadley JA; Lanza DC; Marple BF; Nicklas RA; Bachert C; Baraniuk J; et alBaroody FM; Benninger MS; Brook I; Chowdhury BA; Druce HM; Durham S; Ferguson B; Gwaltney JM; Kaliner M; Kennedy DW; Lund V; Naclerio R; Pawankar R; Piccirillo JF; Rohane P; Simon R; Slavin RG; Togias A; Wald ER; Zinreich SJ; American Academy of Allergy, Asthma and Immunology; American Academy of Otolaryngic Allergy; American Academy of Otolaryngology-Head and Neck Surgery; American College of Allergy, Asthma and Immunology; American Rhinologic Society. (Dec 2004). Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg. 131:S1-62. DOI.
  • Meltzer EO; Hamilos DL; Hadley JA; Lanza DC; Marple BF; Nicklas RA; Bachert C; Baraniuk J; et alBaroody FM; Benninger MS; Brook I; Chowdhury BA; Druce HM; Durham S; Ferguson B; Gwaltney JM; Kaliner M; Kennedy DW; Lund V; Naclerio R; Pawankar R; Piccirillo JF; Rohane P; Simon R; Slavin RG; Togias A; Wald ER; Zinreich SJ; American Academy of Allergy, Asthma and Immunology (AAAAI); American Academy of Otolaryngic Allergy (AAOA); American Academy of Otolaryngology--Head and Neck Surgery (AAO-HNS); American College of Allergy, Asthma and Immunology (ACAAI); American Rhinologic Society (ARS). (Dec 2004). Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 114:155-212. DOI.
  • Bauchau V; Durham SR. (Nov 2004). Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 24:758-764. DOI.
  • Robinson DS; Larché M; Durham SR. (Nov 2004). Tregs and allergic disease. J Clin Invest. 114:1389-1397. DOI.
  • Bachert C; Bousquet J; Canonica GW; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Van Hammée G; et alXPERT Study Group. (Oct 2004). Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol. 114:838-844. DOI.
  • Wilcock LK; Francis JN; Durham SR. (Sep 2004). Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells. Clin Exp Allergy. 34:1373-1378. DOI.
  • Wachholz PA; Durham SR. (Aug 2004). Mechanisms of immunotherapy: IgG revisited. Curr Opin Allergy Clin Immunol. 4:313-318.
  • Durham SR; Wachholz PA; Till SL. (1 Jun 2004). Anti-idiotype antibodies could explain inhibition of allergen-IgE binding to B cells after grass pollen immunotherapy - Reply. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 113:1225-1226. Author weblink DOI.
  • Pilette C; Francis JN; Till SJ; Durham SR. (Jun 2004). CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge. Eur Respir J. 23:876-884.
  • Bousquet J; Boushey HA; Busse WW; Canonica GW; Durham SR; Irvin CG; Karpel JP; Van Cauwenberge P; et alChen R; Iezzoni DG; Harris AG. (Jun 2004). Characteristics of patients with seasonal allergic rhinitis and concomitant asthma. Clin Exp Allergy. 34:897-903. DOI.
  • Till SJ; Francis JN; Nouri-Aria K; Durham SR. (Jun 2004). Mechanisms of immunotherapy. J Allergy Clin Immunol. 113:1025-1034. DOI.
  • Nouri-Aria KT; Durham SR. (1 Mar 2004). Basophils in human allergen-induced late-phase responses. REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE. 44:138-143. Author weblink DOI.
  • Nouri-Aria KT; Wachholz PA; Francis JN; Jacobson MR; Walker SM; Wilcock LK; Staple SQ; Aalberse RC; et alTill SJ; Durham SR. (1 Mar 2004). Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol. 172:3252-3259.
  • Francis JN; Jacobson MR; Lloyd CM; Sabroe I; Durham SR; Till SJ. (1 Jan 2004). CXCR1+CD4+ T cells in human allergic disease. J Immunol. 172:268-273.
  • Till SJ; Durham SR. (2004). Immunological responses to allergen immunotherapy. Clin Allergy Immunol. 18:85-104.
  • Pilette C; Durham SR; Vaerman JP; Sibille Y. (2004). Mucosal immunity in asthma and chronic obstructive pulmonary disease: a role for immunoglobulin A?. Proc Am Thorac Soc. 1:125-135. DOI.
  • Rimaniol AC; Till SJ; Garcia G; Capel F; Godot V; Balabanian K; Durand-Gasselin I; Varga EM; et alSimonneau G; Emilie D; Durham SR; Humbert M. (Dec 2003). The CX3C chemokine fractalkine in allergic asthma and rhinitis. J Allergy Clin Immunol. 112:1139-1146. DOI.
  • Durham SR. (22 Nov 2003). Treatment of seasonal allergic rhinitis - Desensitisation for hay fever works. BRITISH MEDICAL JOURNAL. 327:1229-1229. Author weblink DOI.
  • Coker HA; Durham SR; Gould HJ. (15 Nov 2003). Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol. 171:5602-5610.
  • Wachholz PA; Soni NK; Till SJ; Durham SR. (Nov 2003). Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol. 112:915-922. DOI.
  • Wachholz PA; Durham SR. (Sep 2003). Induction of 'blocking' IgG antibodies during immunotherapy. Clin Exp Allergy. 33:1171-1174.
  • Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR. (Sep 2003). Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis. Rhinology. 41:167-174.
  • Robinson DS; Campbell DA; Durham SR; Pfeffer J; Barnes PJ; Chung KF; Asthma and Allergy Research Group of the National Heart and Lung Institute. (Sep 2003). Systematic assessment of difficult-to-treat asthma. Eur Respir J. 22:478-483.
  • Francis JN; Till SJ; Durham SR. (Jun 2003). Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol. 111:1255-1261.
  • Karagiannis SN; Wang Q; East N; Burke F; Riffard S; Bracher MG; Thompson RG; Durham SR; et alSchwartz LB; Balkwill FR; Gould HJ. (Apr 2003). Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur J Immunol. 33:1030-1040. DOI.
  • Varga EM; Nouri-Aria K; Till SJ; Durham SR. (Mar 2003). Immunomodulatory treatment strategies for allergic diseases. Curr Drug Targets Inflamm Allergy. 2:31-46.
  • Bousquet J; Van Cauwenberge P; Bachert C; Canonica GW; Demoly P; Durham SR; Fokkens W; Lockey R; et alMeltzer EO; Mullol J; Naclerio RM; Price D; Simons FE; Vignola AM; Warner JO; European Academy of Allergy and Clinical Immunology (EAACI); Allergic Rhinitis and its Impact on Asthma (ARIA). (Mar 2003). Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 58:192-197.
  • Wilson DR; Torres LI; Durham SR. (2003). Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. CD002893. DOI.
  • Nouri-Aria KT; Wilson D; Francis JN; Jopling LA; Jacobson MR; Hodge MR; Andrew DP; Till SJ; et alVarga EM; Williams TJ; Pease JE; Lloyd CM; Sabroe I; Durham SR. (Jul 2002). CCR4 in human allergen-induced late responses in the skin and lung. Eur J Immunol. 32:1933-1938. DOI.
  • Sheikh A; Hurwitz B; Sibbald B; Barnes G; Howe M; Durham S. (18 Jun 2002). House dust mite barrier bedding for childhood asthma: randomised placebo controlled trial in primary care [ISRCTN63308372]. BMC Fam Pract. 3:12.
  • Smurthwaite L; Durham SR. (May 2002). Local IgE synthesis in allergic rhinitis and asthma. Curr Allergy Asthma Rep. 2:231-238.
  • Lima MT; Wilson D; Pitkin L; Roberts A; Nouri-Aria K; Jacobson M; Walker S; Durham S. (Apr 2002). Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy. 32:507-514.
  • Ewan PW; Durham SR. (Mar 2002). NHS allergy services in the UK: proposals to improve allergy care. Clin Med. 2:122-127.
  • Varga EM; Durham SR. (2002). Allergen injection immunotherapy. Clin Allergy Immunol. 16:533-549.
  • Bousquet J; Busse WW; Canonica GW; Dahl R; Durham S; Van Cauwenberge P; Chen RD; Harris A; et alIezzoni D. (1 Jan 2002). Asthma symptoms and lung function measurements in subjects with seasonal intermittent asthma (SIA). JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 109:S246-S246. Author weblink DOI.
  • Wachholz PA; Nouri-Aria KT; Wilson DR; Walker SM; Verhoef A; Till SJ; Durham SR. (Jan 2002). Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios. Immunology. 105:56-62.
  • Wilson DR; Merrett TG; Varga EM; Smurthwaite L; Gould HJ; Kemp M; Hooper J; Till SJ; et alDurham SR. (1 Jan 2002). Increases in allergen-specific IgE in BAL after segmental allergen challenge in atopic asthmatics. Am J Respir Crit Care Med. 165:22-26.
  • Smurthwaite L; Walker SN; Wilson DR; Birch DS; Merrett TG; Durham SR; Gould HJ. (Dec 2001). Persistent IgE synthesis in the nasal mucosa of hay fever patients. Eur J Immunol. 31:3422-3431. DOI.
  • Wilson DR; Irani AM; Walker SM; Jacobson MR; Mackay IS; Schwartz LB; Durham SR. (Nov 2001). Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy. 31:1705-1713.
  • Nouri-Aria KT; Irani AM; Jacobson MR; O'brien F; Varga EM; Till SJ; Durham SR; Schwartz LB. (Aug 2001). Basophil recruitment and IL-4 production during human allergen-induced late asthma. J Allergy Clin Immunol. 108:205-211. DOI.
  • Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR. (Jun 2001). Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol. 107:971-976. DOI.
  • Ying S; Humbert M; Meng Q; Pfister R; Menz G; Gould HJ; Kay AB; Durham SR. (Apr 2001). Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J Allergy Clin Immunol. 107:686-692.
  • Till S; Jopling L; Wachholz P; Robson R; Qin S; Andrew D; Wu L; van Neerven J; et alWilliams T; Durham S; Sabroe I. (15 Feb 2001). T cell phenotypes of the normal nasal mucosa: induction of Th2 cytokines and CCR3 expression by IL-4. J Immunol. 166:2303-2310.
  • Till SJ; Jacobson MR; O'Brien F; Durham SR; KleinJan A; Fokkens WJ; Juliusson S; Löwhagen O. (Feb 2001). Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy. Allergy. 56:126-131.
  • Walker SM; Pajno GB; Lima MT; Wilson DR; Durham SR. (Jan 2001). Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol. 107:87-93. DOI.
  • Nouri-Aria KT; O'Brien F; Noble W; Jabcobson MR; Rajakulasingam K; Durham SR. (Dec 2000). Cytokine expression during allergen-induced late nasal responses: IL-4 and IL-5 mRNA is expressed early (at 6 h) predominantly by eosinophils. Clin Exp Allergy. 30:1709-1716.
  • Durham SR; Till SJ; Corrigan CJ. (Nov 2000). T lymphocytes in asthma: bronchial versus peripheral responses. J Allergy Clin Immunol. 106:S221-S226.
  • Durham SR; Smurthwaite L; Gould HJ. (Sep 2000). Local IgE production. Am J Rhinol. 14:305-307.
  • Varga EM; Wachholz P; Nouri-Aria KT; Verhoef A; Corrigan CJ; Till SJ; Durham SR. (1 Sep 2000). T cells from human allergen-induced late asthmatic responses express IL-12 receptor beta 2 subunit mRNA and respond to IL-12 in vitro. J Immunol. 165:2877-2885.
  • Laberge S; Pinsonneault S; Varga EM; Till SJ; Nouri-Aria K; Jacobson M; Cruikshank WW; Center DM; et alHamid Q; Durham SR. (1 Aug 2000). Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 106:293-301. Author weblink.
  • Cameron L; Hamid Q; Wright E; Nakamura Y; Christodoulopoulos P; Muro S; Frenkiel S; Lavigne F; et alDurham S; Gould H. (1 Jul 2000). Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 106:46-52. Author weblink.
  • Christodoulopoulos P; Cameron L; Durham S; Hamid Q. (1 Feb 2000). Molecular pathology of allergic disease - II: Upper airway disease. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 105:211-223. Author weblink DOI.
  • Durham SR; Walker S. (2000). Immunotherapy for hayfever. Chem Immunol. 78:199-208.
  • Passalacqua G; Albano M; Canonica GW; Bachert C; Van Cauwenberge P; Davies RJ; Durham SR; Kontou-Fili K; et alHorak F; Malling HJ. (1 Jan 2000). Inhaled and nasal corticosteroids: safety aspects. ALLERGY. 55:16-33. Author weblink DOI.
  • Smurthwaite L; Durham S; Gould H. (1 Jan 2000). Local IgE synthesis in the nasal mucosa. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 105:S359-S359. Author weblink DOI.
  • Durham SR; Varney VA; Gaga M; Jacobson MR; Varga EM; Frew AJ; Kay AB. (Nov 1999). Grass pollen immunotherapy decreases the number of mast cells in the skin. Clin Exp Allergy. 29:1490-1496.
  • Humbert M; Menz G; Ying S; Corrigan CJ; Robinson DS; Durham SR; Kay AB. (1 Nov 1999). The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. IMMUNOLOGY TODAY. 20:528-533. Author weblink DOI.
  • Jacobson MR; Juliusson S; Löwhagen O; Balder B; Kay AB; Durham SR. (Oct 1999). Effect of topical corticosteroids on seasonal increases in epithelial eosinophils and mast cells in allergic rhinitis: a comparison of nasal brush and biopsy methods. Clin Exp Allergy. 29:1347-1355.
  • Varga EM; Jacobson MR; Masuyama K; Rak S; Till SJ; Darby Y; Hamid Q; Lund V; et alScadding GK; Durham SR. (Sep 1999). Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis. Eur Respir J. 14:610-615.
  • Durham SR; Walker SM; Varga EM; Jacobson MR; O'Brien F; Noble W; Till SJ; Hamid QA; et alNouri-Aria KT. (12 Aug 1999). Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 341:468-475. DOI.
  • Durham S. (1 Aug 1999). Long acting inhaled beta(2)-agonists: anti-inflammatory effects not evident during treatment of day to day asthma. EUROPEAN RESPIRATORY JOURNAL. 14:249-250. Author weblink DOI.
  • Dubois AEJ; de Monchy GR; Schouten JP; Durham S; Golden DBK; Rak S; Weiss ST. (1 Jul 1999). Letter to the editor. ALLERGY. 54:760-762. Author weblink DOI.
  • Varga EM; Jacobson MR; Till SJ; Masuyama K; O'Brien F; Rak S; Lund V; Scadding GK; et alHamid QA; Durham SR. (Apr 1999). Cellular infiltration and cytokine mRNA expression in perennial allergic rhinitis. Allergy. 54:338-345.
  • Alton EW; Stern M; Farley R; Jaffe A; Chadwick SL; Phillips J; Davies J; Smith SN; et alBrowning J; Davies MG; Hodson ME; Durham SR; Li D; Jeffery PK; Scallan M; Balfour R; Eastman SJ; Cheng SH; Smith AE; Meeker D; Geddes DM. (20 Mar 1999). Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet. 353:947-954.
  • Durham SR. (1999). Effect of intranasal corticosteroid treatment on asthma in children and adults. Allergy. 54 Suppl 57:124-131.
  • Nouri-Aria KT; Masuyama K; Jacobson MR; Rak S; Lowhagen O; Schotman E; Hamid Q; Durham SR. (1 Dec 1998). Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: Cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 117:248-254. Author weblink DOI.
  • Stirling RG; Kharitonov SA; Campbell D; Robinson DS; Durham SR; Chung KF; Barnes PJ. (Dec 1998). Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group. Thorax. 53:1030-1034.
  • Durham SR. (Dec 1998). The inflammatory nature of allergic disease. Clin Exp Allergy. 28 Suppl 6:20-24.
  • Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; et alHamid QA; Durham SR. (Oct 1998). Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids. J Allergy Clin Immunol. 102:610-617.
  • Till SJ; Durham SR; Rajakulasingam K; Humbert M; Huston D; Dickason R; Kay AB; Corrigan CJ. (Aug 1998). Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge. Am J Respir Crit Care Med. 158:404-411.
  • Durham SR; Till SJ. (Aug 1998). Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol. 102:157-164.
  • Gaga M; Bentley AM; Humbert M; Barkans J; O'Brien F; Wathen CG; Kay AB; Durham SR. (Aug 1998). Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax. 53:685-691.
  • Rajakulasingam K; Till S; Ying S; Humbert M; Barkans J; Sullivan M; Meng Q; Corrigan CJ; et alBungre J; Grant JA; Kay AB; Durham SR. (Jul 1998). Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma. Am J Respir Crit Care Med. 158:233-240.
  • Durham SR. (Jun 1998). Mechanisms of mucosal inflammation in the nose and lungs. CLIN EXP ALLERGY. 28:11-16.
  • Vervloet D; Durham S. (16 May 1998). ABC of allergies - Adverse reactions to drugs. BRITISH MEDICAL JOURNAL. 316:1511-1514. Author weblink.
  • Minshall E; Ghaffar O; Cameron L; O'Brien F; Quinn H; Rowe-Jones J; Davies RJ; Prior A; et alLund VJ; Mackay IS; Nolop K; Lutsky B; Durham SR; Hamid Q. (1 May 1998). Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. OTOLARYNGOLOGY-HEAD AND NECK SURGERY. 118:648-654. Author weblink DOI.
  • Ghaffar O; Durham SR; Al-Ghamdi K; Wright E; Small P; Frenkiel S; Gould HJ; Hamid Q. (1 May 1998). Expression of IgE heavy chain transcripts in the sinus mucosa of atopic and nonatopic patients with chronic sinusitis. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 18:706-711. Author weblink.
  • Mackay IS; Durham SR. (21 Mar 1998). ABC of allergies. Perennial rhinitis. BMJ. 316:917-920.
  • Durham S. (14 Mar 1998). ABC of allergies - Summer hay fever. BRITISH MEDICAL JOURNAL. 316:843-845. Author weblink.
  • Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; et alHamid OA. (1 Mar 1998). Expression of IL-4, C epsilon RNA, and I epsilon RNA in the nasal mucosa of patients with seasonal rhinitis: Effect of topical corticosteroids. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 101:330-336. Author weblink.
  • Ying S; Barata LT; Meng Q; Grant JA; Barkans J; Durham SR; Kay AB. (Feb 1998). High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans' cells in allergen-induced late-phase cutaneous reactions in atopic subjects. Immunology. 93:281-288.
  • Barata LT; Ying S; Meng Q; Barkans J; Rajakulasingam K; Durham SR; Kay AB. (Feb 1998). IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Allergy Clin Immunol. 101:222-230.
  • Durham S. (1998). The many faces of asthma. Introduction. Proceedings from a symposium held at the annual meeting of the European Academy of Allergology and Clinical Immunology in Rhodes Greece, June 1997. Allergy. 53:5-6.
  • Ying S; Robinson DS; Meng Q; Rottman J; Kennedy R; Ringler DJ; Mackay CR; Daugherty BL; et alSpringer MS; Durham SR; Williams TJ; Kay AB. (Dec 1997). Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol. 27:3507-3516. DOI.
  • Durham SR; Gould HJ; Thienes CP; Jacobson MR; Masuyama K; Rak S; Lowhagen O; Schotman E; et alCameron L; Hamid QA. (Nov 1997). Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol. 27:2899-2906. DOI.
  • Laberge S; Durham SR; Ghaffar O; Rak S; Center DM; Jacobson M; Hamid Q. (1 Oct 1997). Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 100:569-574. Author weblink.
  • Till S; Walker S; Dickason R; Huston D; O'Brien F; Lamb J; Kay AB; Corrigan C; et alDurham S. (Oct 1997). IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis. Clin Exp Immunol. 110:114-121.
  • Humbert M; Corrigan CJ; Kimmitt P; Till SJ; Kay AB; Durham SR. (Sep 1997). Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med. 156:704-708.
  • Sibbald B; Barnes G; Durham SR. (1 Sep 1997). Skin prick testing in general practice: A pilot study. JOURNAL OF ADVANCED NURSING. 26:537-542. Author weblink DOI.
  • Rajakulasingam K; Durham SR; O'Brien F; Humbert M; Barata LT; Reece L; Kay AB; Grant JA. (Jul 1997). Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells. J Allergy Clin Immunol. 100:78-86.
  • Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q. (1 Jul 1997). IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: Comparison with IL-4 expression and modulation by topical glucocorticoid therapy. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 17:17-24. Author weblink.
  • Ying S; Meng Q; Barata LT; Robinson DS; Durham SR; Kay AB. (15 May 1997). Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Immunol. 158:5050-5057.
  • Barata LT; Ying S; Grant JA; Humbert M; Barkans J; Meng Q; Durham SR; Kay AB. (May 1997). Allergen-induced recruitment of Fc epsilon RI+ eosinophils in human atopic skin. Eur J Immunol. 27:1236-1241. DOI.
  • Sihra BS; Kon OM; Durham SR; Walker S; Barnes NC; Kay AB. (May 1997). Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax. 52:447-452.
  • Humbert M; Durham SR; Kimmitt P; Powell N; Assoufi B; Pfister R; Menz G; Kay AB; et alCorrigan CJ. (May 1997). Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol. 99:657-665.
  • Kay AB; Barata L; Meng Q; Durham SR; Ying S. (May 1997). Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol. 113:196-199.
  • Till S; Durham S; Dickason R; Huston D; Bungre J; Walker S; Robinson D; Kay AB; et alCorrigan C. (May 1997). IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression. Immunology. 91:53-57.
  • Kotsimbos ATC; Humbert M; Minshall E; Durham S; Pfister R; Menz G; Tavernier J; Kay AB; et alHamid Q. (1 May 1997). Upregulation of alpha GM-CSF-receptor in nonatopic asthma but not in atopic asthma. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 99:666-672. Author weblink DOI.
  • Ying S; Humbert M; Barkans J; Corrigan CJ; Pfister R; Menz G; Larché M; Robinson DS; et alDurham SR; Kay AB. (1 Apr 1997). Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol. 158:3539-3544.
  • Till S; Dickason R; Huston D; Humbert M; Robinson D; Larché M; Durham S; Kay AB; et alCorrigan C. (Apr 1997). IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease. J Allergy Clin Immunol. 99:563-569.
  • Yasruel Z; Humbert M; Kotsimbos TC; Ploysongsang Y; Minshall E; Durham SR; Pfister R; Menz G; et alTavernier J; Kay AB; Hamid Q. (1 Apr 1997). Membrane-bound and soluble alpha IL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 155:1413-1418. Author weblink.
  • Li D; Wang D; Majumdar S; Jany B; Durham SR; Cottrell J; Caplen N; Geddes DM; et alAlton EW; Jeffery PK. (Mar 1997). Localization and up-regulation of mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis. J Pathol. 181:305-310. DOI.
  • Hamid QA; Schotman E; Jacobson MR; Walker SM; Durham SR. (1 Feb 1997). Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 99:254-260. Author weblink DOI.
  • Rajakulasingam K; Hamid Q; O'Brien F; Shotman E; Jose PJ; Williams TJ; Jacobson M; Barkans J; et alDurham SR. (Feb 1997). RANTES in human allergen-induced rhinitis: cellular source and relation to tissue eosinophilia. Am J Respir Crit Care Med. 155:696-703.
  • Humbert M; Ying S; Corrigan C; Menz G; Barkans J; Pfister R; Meng Q; Van Damme J; et alOpdenakker G; Durham SR; Kay AB. (Jan 1997). Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am J Respir Cell Mol Biol. 16:1-8.
  • Grant JA; Humbert M; TabordaBarata L; Sihra BS; Kon OM; Rajakulasingam K; Durham SR; Kay AB. (1 Jan 1997). High-affinity IgE receptor fc epsilon RI expression in allergic reactions. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 113:376-378. Author weblink.
  • Durham SR; Gould HJ; Hamid QA. (May 1997). Local IgE production in nasal allergy. Int Arch Allergy Immunol. 113:128-130.
  • Kharitonov SA; Rajakulasingam K; O'Connor B; Durham SR; Barnes PJ. (Jan 1997). Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol. 99:58-64.
  • Powell N; Humbert M; Durham SR; Assoufi B; Kay AB; Corrigan CJ. (Dec 1996). Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur Respir J. 9:2454-2460.
  • Humbert M; Durham SR; Ying S; Kimmitt P; Barkans J; Assoufi B; Pfister R; Menz G; et alRobinson DS; Kay AB; Corrigan CJ. (Nov 1996). IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med. 154:1497-1504.
  • Durham SR. (1 Sep 1996). Allergen avoidance measures. RESPIRATORY MEDICINE. 90:441-445. Author weblink DOI.
  • Durham SR. (Sep 1996). Allergen avoidance measures. British Thoracic Society. Respir Med. 90:441-445.
  • Humbert M; Robinson DS; Assoufi B; Kay AB; Durham SR. (Jul 1996). Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks. Thorax. 51:664-669.
  • Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA. (Jun 1996). Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol. 97:1356-1365.
  • Humbert M; Grant JA; Taborda-Barata L; Durham SR; Pfister R; Menz G; Barkans J; Ying S; et alKay AB. (Jun 1996). High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med. 153:1931-1937.
  • Robinson DS; Tsicopoulos A; Meng Q; Durham S; Kay AB; Hamid Q. (Feb 1996). Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol. 14:113-117.
  • Bentley AM; Hamid Q; Robinson DS; Schotman E; Meng Q; Assoufi B; Kay AB; Durham SR. (Feb 1996). Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med. 153:551-556.
  • Ying S; Meng Q; Taborda-Barata L; Corrigan CJ; Barkans J; Assoufi B; Moqbel R; Durham SR; et alKay AB. (Jan 1996). Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur J Immunol. 26:70-76. DOI.
  • Moqbel R; Ying S; Barkans J; Newman TM; Kimmitt P; Wakelin M; Taborda-Barata L; Meng Q; et alCorrigan CJ; Durham SR; Kay AB. (15 Nov 1995). Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol. 155:4939-4947.
  • Robinson DS; Assoufi B; Durham SR; Kay AB. (Nov 1995). Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin Exp Allergy. 25:1118-1127.
  • Till S; Li B; Durham S; Humbert M; Assoufi B; Huston D; Dickason R; Jeannin P; et alKay AB; Corrigan C. (Oct 1995). Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls. Eur J Immunol. 25:2727-2731. DOI.
  • Durham SR; Kay AB; Hamid Q. (May 1995). Changes in allergic inflammation associated with successful immunotherapy. Int Arch Allergy Immunol. 107:282-284.
  • Walker SM; Varney VA; Gaga M; Jacobson MR; Durham SR. (May 1995). Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study. Allergy. 50:405-413.
  • Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB. (May 1995). Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol. 12:567-578.
  • Ying S; Durham SR; Corrigan CJ; Hamid Q; Kay AB. (May 1995). Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol. 12:477-487.
  • Kay AB; Ying S; Durham SR. (May 1995). Phenotype of cells positive for interleukin-4 and interleukin-5 mRNA in allergic tissue reactions. Int Arch Allergy Immunol. 107:208-210.
  • CAPLEN NJ; ALTON EWFW; MIDDLETON PG; DORIN J; STEVENSON BJ; GAO X; DURHAM S; JEFFERY PK; et alHODSON ME; COUTELLE C; HUANG L; PORTEOUS DJ; WILLIAMSON R; GEDDES DM. (1 Jan 1995). LIPOSOME-MEDIATED CFTR GENE-TRANSFER TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS. NATURE MEDICINE. 1:39-46. Author weblink DOI.
  • Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; et alDurham SR. (Oct 1994). Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy. 24:930-939.
  • TSICOPOULOS A; HAMID Q; HACZKU A; JACOBSON MR; DURHAM S; NORTH J; BARKANS J; CORRIGAN CJ; et alMENG Q; MOQBEL R; KAY AB. (1 Oct 1994). KINETICS OF CELL INFILTRATION AND CYTOKINE MESSENGER-RNA EXPRESSION AFTER INTRADERMAL CHALLENGE WITH ALLERGEN AND TUBERCULIN IN THE SAME ATOPIC INDIVIDUALS. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 94:764-772. Author weblink DOI.
  • Bentley AM; Durham SR; Kay AB. (Sep 1994). Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma. J Investig Allergol Clin Immunol. 4:222-232.
  • Varney VA; Cumberworth V; Sudderick R; Durham SR; Mackay IS. (Jun 1994). Rhinitis, sinusitis and the yellow nail syndrome: a review of symptoms and response to treatment in 17 patients. Clin Otolaryngol Allied Sci. 19:237-240.
  • Bentley AM; Durham SR; Robinson DS; Menz G; Storz C; Cromwell O; Kay AB; Wardlaw AJ. (Dec 1993). Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J Allergy Clin Immunol. 92:857-868.
  • DURHAM S. (20 Oct 1993). MEDICAL APPROACH TO RHINITIS. BRITISH JOURNAL OF HOSPITAL MEDICINE. 50:458-&. Author weblink.
  • Durham SR. (20 Oct 1993). Medical approach to rhinitis. Br J Hosp Med. 50:458-462.
  • Ying S; Durham SR; Barkans J; Masuyama K; Jacobson M; Rak S; Löwhagen O; Moqbel R; et alKay AB; Hamid QA. (Oct 1993). T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol. 9:356-360.
  • Robinson DS; Ying S; Bentley AM; Meng Q; North J; Durham SR; Kay AB; Hamid Q. (Sep 1993). Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol. 92:397-403.
  • Robinson D; Hamid Q; Bentley A; Ying S; Kay AB; Durham SR. (Aug 1993). Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol. 92:313-324.
  • Robinson DS; Durham SR; Kay AB. (Aug 1993). Cytokines. 3. Cytokines in asthma. Thorax. 48:845-853.
  • Robinson D; Hamid Q; Ying S; Bentley A; Assoufi B; Durham S; Kay AB. (Aug 1993). Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am Rev Respir Dis. 148:401-406.
  • Corrigan CJ; Haczku A; Gemou-Engesaeth V; Doi S; Kikuchi Y; Takatsu K; Durham SR; Kay AB. (Mar 1993). CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis. 147:540-547.
  • Robinson DS; Bentley AM; Hartnell A; Kay AB; Durham SR. (Jan 1993). Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax. 48:26-32.
  • Robinson DS; Hamid Q; Jacobson M; Ying S; Kay AB; Durham SR. (1993). Evidence for Th2-type T helper cell control of allergic disease in vivo. Springer Semin Immunopathol. 15:17-27.
  • Varney VA; Jacobson MR; Sudderick RM; Robinson DS; Irani AM; Schwartz LB; Mackay IS; Kay AB; et alDurham SR. (Jul 1992). Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis. 146:170-176.
  • DURHAM S; YING S; VARNEY VA; JACOBSON MR; SUDDERICK RM; MACKAY IS; KAY AB; HAMID QA. (15 Apr 1992). CYTOKINE MESSENGER-RNA EXPRESSION FOR IL-3, IL-4, IL-5, AND GRANULOCYTE/MACROPHAGE-COLONY-STIMULATING FACTOR IN THE NASAL-MUCOSA AFTER LOCAL ALLERGEN PROVOCATION - RELATIONSHIP TO TISSUE EOSINOPHILIA. JOURNAL OF IMMUNOLOGY. 148:2390-2394. Author weblink.
  • Hamid Q; Barkans J; Robinson DS; Durham SR; Kay AB. (Apr 1992). Co-expression of CD25 and CD3 in atopic allergy and asthma. Immunology. 75:659-663.
  • Bentley AM; Jacobson MR; Cumberworth V; Barkans JR; Moqbel R; Schwartz LB; Irani AM; Kay AB; et alDurham SR. (Apr 1992). Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol. 89:877-883.
  • Tsicopoulos A; Hamid Q; Varney V; Ying S; Moqbel R; Durham SR; Kay AB. (1 Apr 1992). Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol. 148:2058-2061.
  • Moqbel R; Barkans J; Bradley BL; Durham SR; Kay AB. (Feb 1992). Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin Exp Allergy. 22:265-273.
  • Robinson DS; Hamid Q; Ying S; Tsicopoulos A; Barkans J; Bentley AM; Corrigan C; Durham SR; et alKay AB. (30 Jan 1992). Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 326:298-304. DOI.
  • Chung KF; Durham SR. (Jan 1992). Asthma as an inflammatory disease: clinical perspectives. Br Med Bull. 48:179-189.
  • Ying S; Robinson DS; Varney V; Meng Q; Tsicopoulos A; Moqbel R; Durham SR; Kay AB; et alHamid Q. (Nov 1991). TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy. 21:745-750.
  • BRADLEY BL; AZZAWI M; JACOBSON M; ASSOUFI B; COLLINS JV; IRANI AMA; SCHWARTZ LB; DURHAM S; et alJEFFERY PK; KAY AB. (1 Oct 1991). EOSINOPHILS, T-LYMPHOCYTES, MAST-CELLS, NEUTROPHILS, AND MACROPHAGES IN BRONCHIAL BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITH ASTHMA - COMPARISON WITH BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITHOUT ASTHMA AND NORMAL CONTROL SUBJECTS AND RELATIONSHIP TO BRONCHIAL HYPERRESPONSIVENESS. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 88:661-674. Author weblink DOI.
  • HAMID Q; AZZAWI M; YING S; MOQBEL R; WARDLAW AJ; CORRIGAN CJ; BRADLEY B; DURHAM S; et alCOLLINS JV; JEFFERY PK; QUINT DJ; KAY AB. (1 May 1991). EXPRESSION OF MESSENGER-RNA FOR INTERLEUKIN-5 IN MUCOSAL BRONCHIAL BIOPSIES FROM ASTHMA. JOURNAL OF CLINICAL INVESTIGATION. 87:1541-1546. Author weblink DOI.
  • Hayes JP; Lambourn L; Hopkirk JA; Durham SR; Taylor AJ. (May 1991). Occupational asthma due to styrene. Thorax. 46:396-397.
  • KAY AB; VARNEY VA; DURHAM S. (2 Mar 1991). IMMUNOTHERAPY AND HAY-FEVER - REPLY. BRITISH MEDICAL JOURNAL. 302:531-531. Author weblink.
  • Varney VA; Gaga M; Frew AJ; Aber VR; Kay AB; Durham SR. (2 Feb 1991). Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ. 302:265-269.
  • HAMID Q; AZZAWI M; YING S; MOQBEL R; WARDLAW AJ; CORRIGAN CJ; BRADLEY B; DURHAM S; et alCOLLINS JV; JEFFERY PK; QUINT DJ; KAY AB. (1 Jan 1991). INTERLEUKIN-5 MESSENGER-RNA IN MUCOSAL BRONCHIAL BIOPSIES FROM ASTHMATIC SUBJECTS. INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY. 94:169-170. Author weblink.
  • Azzawi M; Bradley B; Jeffery PK; Frew AJ; Wardlaw AJ; Knowles G; Assoufi B; Collins JV; et alDurham S; Kay AB. (Dec 1990). Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis. 142:1407-1413.
  • Durham SR. (Jul 1990). Late asthmatic responses. Respir Med. 84:263-268.

Conferences

  • Wu H; Orban N; Jacobson M; Lee D; Durham SR. Effects of Repetitive Allergen Challenge on Expression of TGF-beta, Activin -A and Its Receptor ALK4 in Nasal Mucosa of Allergic Rhinitis. Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI), 2 Mar 2012 - 6 Mar 2012. 129:AB208-AB208. MOSBY-ELSEVIER (1 Feb 2012).
  • Achkova D; Chung FW; Leyhadi JA; Scadding GW; Charlesworth J; Phippard D; Durham S; Shamji MH. Interleukin-35 Suppresses Allergen-specific Th2 Response in Patients with Grass pollen induced Seasonal Allergic Rhinitis. Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI), 2 Mar 2012 - 6 Mar 2012. 129:AB208-AB208. MOSBY-ELSEVIER (1 Feb 2012).
  • Shamji MH; Bellido V; Scadding G; Leyhadi JA; Calderon M; Togias A; Tchao N; Plaut M; et alTurka L; Phippard D; Durham S. Effects of Nasal Allergen Challenge on T cell signature in Peripheral Blood in Patients with Severe Seasonal Allergic Rhinitis. Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI), 2 Mar 2012 - 6 Mar 2012. 129:AB196-AB196. MOSBY-ELSEVIER (1 Feb 2012).
  • Eifan A; Orban N; Jacobson M; Lee D; Nouri-Aria K; Durham SR. Impact of repetitive allergen challenge on angiogenesis & lymphangiogenesis in allergic rhinitis. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology (BSACI), 11 Jul 2011 - 13 Jul 2011. 41:1837-1837. WILEY-BLACKWELL (1 Dec 2011). Author weblink.
  • Shamji M; Hamilton A; Harris J; Jeal H; Cullinan P; Durham SR; Jones M. Is 'natural tolerance' at high allergen exposure associated with inhibitory IgG4 antibodies?. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology (BSACI), 11 Jul 2011 - 13 Jul 2011. 41:1833-1833. WILEY-BLACKWELL (1 Dec 2011). Author weblink.
  • Shamji M; Layhadi JA; Cheung DKM; Khan SQ; Durham SR. Allergen-induced expression of CD203c, CD63 and CD107a on CRTH2+ basophils: Biomarkers for monitoring efficacy of grass pollen immunotherapy. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology (BSACI), 11 Jul 2011 - 13 Jul 2011. 41:1823-1823. WILEY-BLACKWELL (1 Dec 2011). Author weblink.
  • Scadding G; Bellido V; Calderon M; Durham SR; Koed GK; Nielsen NC; Wurtzen PA. Nasal allergen challenge in grass pollen allergic rhinitics: symptom scores and local biomarkers. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology (BSACI), 11 Jul 2011 - 13 Jul 2011. 41:1833-1834. WILEY-BLACKWELL (1 Dec 2011). Author weblink.
  • James L; Bowen H; Goldstone A; Durham SR; Gould HJ. Generation of a high affinity Phl p 7-specific IgG4 antibody. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology (BSACI), 11 Jul 2011 - 13 Jul 2011. 41:1832-1832. WILEY-BLACKWELL (1 Dec 2011). Author weblink.
  • Shamji MH; Chaker A; Cheung D; Poon M; Schmidt-Weber C; Durham SR; Durham SR. Frequency Of Grass Pollen-specific Il-4, Il-10 And Dual Il-4 And Il10 Positive Cells In Atopic And Non-atopic Individuals In And Out Of The Pollen Season. American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting, 18 Mar 2011 - 22 Mar 2011. 127:AB128-AB128. MOSBY-ELSEVIER (1 Feb 2011). Author weblink DOI.
  • Nicholson J; Ratnayake AR; Poon M; Togias A; Durham S; Shamji M. Ige-facilitated Binding Of Cockroach Allergen-ige Complexes To B Cells: An Assay To Monitor Efficacy During Immunotherapy?. American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting, 18 Mar 2011 - 22 Mar 2011. 127:AB225-AB225. MOSBY-ELSEVIER (1 Feb 2011). Author weblink DOI.
  • Nolte H; Nelson HS; Blaiss M; Bufe A; Dahl R; Durham SR. Lower Respiratory-Related Events in Adults and Children With Allergic Rhinoconjunctivitis Receiving Timothy Grass Allergy Immunotherapy Tablet. American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting, 18 Mar 2011 - 22 Mar 2011. 127:AB48-AB48. MOSBY-ELSEVIER (1 Feb 2011). Author weblink DOI.
  • Dreborg S; Lee T; Kay AB; Durham SR. Subcutaneous Immunotherapy (SCIT) Is Allergen-specific: A Double-blind Trial Of Mite Or Timothy Extract In Mite And Grass Dual Allergic Patients. American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting, 18 Mar 2011 - 22 Mar 2011. 127:AB219-AB219. MOSBY-ELSEVIER (1 Feb 2011). Author weblink DOI.
  • Shamji M; Ljorring C; Francis JN; Kimber I; Frew AJ; Lund K; Wurtzen PA; Durham SR. Blocking Antibodies: Relationship between IgG4-associated Inhibitory Activity and Clinical Response to Grass-Pollen Immunotherapy. 66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 26 Feb 2010 - 2 Mar 2010. 125:AB131-AB131. MOSBY-ELSEVIER (1 Feb 2010).
  • Nouri-Aria KT; Wu H; Gevaert P; Takhar P; Bachert C; Durham SR; Gould HJ. Nasal RAG1-and RAG2-Expressing Cells May Suggest the Nose As A Tertiary Lymphoid Organ. 66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 26 Feb 2010 - 2 Mar 2010. 125:AB204-AB204. MOSBY-ELSEVIER (1 Feb 2010). Author weblink.
  • Skypala IJ; Bull SC; Deegan K; Gruffydd-Jones K; Holmes S; Small I; Emery P; Durham S. Prevalence of pollen-related Oral Allergy Syndrome (OAS) in a UK population. 66th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 26 Feb 2010 - 2 Mar 2010. 125:AB218-AB218. MOSBY-ELSEVIER (1 Feb 2010).
  • Shamji MH; Ljorring C; Francis JN; Kimber I; Frew AJ; Lund K; Wurtzen PA; Durham SR. Functional antibodies: a time-dependent and dose-related response following grass pollen immunotherapy. Annual Conference of the British-Society-for-Allergy-and-Clinical-Immunology, 29 Jun 2009 - 1 Jul 2009. 39:1939-1939. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2009). Author weblink.
  • Saggar L; Petalas K; Schmidt-Weber C; Goldstone A; Durham SR; Till SJ. IL-10 and ICOS ligand expression by plasmacytoid dendritic cells in allergic and non-allergic subjects. Annual Conference of the British-Society-for-Allergy-and-Clinical-Immunology, 29 Jun 2009 - 1 Jul 2009. 39:1941-1942. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2009). Author weblink.
  • Scadding GW; Shamji MH; Jacobson MR; Lee DI; Kimber I; Schmidt-Weber CB; Nouri-Aria K; Durham SR. Local mucosal and systemic regulatory effects of grass pollen sublingual immunotherapy. Annual Conference of the British-Society-for-Allergy-and-Clinical-Immunology, 29 Jun 2009 - 1 Jul 2009. 39:1938-1938. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2009). Author weblink.
  • Durham SR; Dahl R; Scadding G; Kapp A; Colombo G; de Monchy JGR; Rak S; Riis B; et alEmminger W. Sustained, disease-modifying effect of grass allergy tablet immunotherapy 1 year after a 3-year treatment period. Annual Conference of the British-Society-for-Allergy-and-Clinical-Immunology, 29 Jun 2009 - 1 Jul 2009. 39:1944-1944. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2009). Author weblink.
  • Calderon M; Penagos M; Sheikh A; Canonica G; Durham S. Efficacy of sublingual immunotherapy (SLIT) in treating allergic conjunctivitis (AC). A Cochrane systematic review and meta-analysis. 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 6 Jun 2009 - 10 Jun 2009. 64:469-469. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • Scadding G; Shamji M; Jacobson M; Schmidt-Weber C; Nouri-Aria K; Durham S. Foxp3 is increased in the sublingual mucosa after grass pollen sublingual immunotherapy and is accompanied by increases in serum IgG4 and serum inhibitory activity for allergen-IgE binding to B cells. 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 6 Jun 2009 - 10 Jun 2009. 64:93-93. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • Bufe A; Henmar H; Gronager P; Durham S. Grass allergen tablet immunotherapy in children induces IgG(4) antibody and IgE-blocking responses similar to those seen in adults. 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 6 Jun 2009 - 10 Jun 2009. 64:358-358. WILEY-BLACKWELL (1 Jan 2009). Author weblink.
  • Shamji M; James L; Francis J; Kimber I; Till S; Durham S. Long-term remission after withdrawal of subcutaneous immunotherapy is associated with persistent elevated serum IgG4-dependent inhibitory activity that is not detectable by measuring serum immunoreactive allergen-specific IgG4 antibody levels. 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 6 Jun 2009 - 10 Jun 2009. 64:227-227. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • Emminger W; Andersen J; Durham S. SQ-standardised grass allergy immunotherapy tablet provides consistent reductions in all individual nose and eye seasonal symptoms compared to symptomatic medication alone 1 year after treatment. 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 6 Jun 2009 - 10 Jun 2009. 64:548-548. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • Durham S; Dahl R; Kapp A; Colombo G; de Monchy J; Rak S; Riis B; Emminger W. Sustained, disease-modifying effect of grass allergen tablet immunotherapy 1 year after completion of treatment. 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 6 Jun 2009 - 10 Jun 2009. 64:146-146. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • Dahl R; Durham S; Kapp A; Colombo G; de Monchy J; Emminger W; Tholstrup B; Rak S. The improvement in disease specific quality of life is sustained 1 year after completion of 3 years treatment with the a grass allergen immunotherapy tablet. 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 6 Jun 2009 - 10 Jun 2009. 64:150-151. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • Ljorring C; Shamji MH; Wuertzen PA; Lund K; Frew AJ; Durham SR; Ipsen H. IgE-blocking Antibodies may account for a large Proportion of the observed Treatment Effect Induced by Specific Immunotherapy (SIT). 65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 13 Mar 2009 - 17 Mar 2009. 123:S154-S154. MOSBY-ELSEVIER (1 Feb 2009). Author weblink DOI.
  • Skypala IJ; McKenzie R; Cholet A; Leeds A; Durham SR. Oral Allergy Syndrome (OAS): The Natural History of Reported Reactions and Extent of Sensitisation to Plant Foods. 65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 13 Mar 2009 - 17 Mar 2009. 123:S31-S31. MOSBY-ELSEVIER (1 Feb 2009). Author weblink DOI.
  • Bufe A; Henmar H; Gronager PM; Durham SR. Sublingual Immunotherapy with Fast-Dissolving Grass Tablets Induces Comparable IgG(4) Antibody and IgE-blocking Responses in Children and Adults. 65th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 13 Mar 2009 - 17 Mar 2009. 123:S75-S75. MOSBY-ELSEVIER (1 Feb 2009). Author weblink DOI.
  • Emminger W; Dahl R; Kapp A; Colombo G; de Monchy J; Rak S; Denlow B; Durham S. Continuous clinical efficacy and progressive immunological effect of long-term specific immunotherapy with the ALK grass allergen tablet: Findings from a 3-year randomised adult trial. 27th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology. 63:614-614.
  • Durham S; Andersen J. Grass allergen tablet immunotherapy significantly reduces the risk of having "days with severe symptoms'' during the pollen season. 27th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology, 7 Jun 2008 - 11 Jun 2008. 63:230-231. BLACKWELL PUBLISHING (1 Jan 2008). Author weblink.
  • Andersen J; Durham S; Emminger W. Increased clinical effect of the ALK grass allergen tablet over 3 years of continued treatment. 27th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology. 63:639-639.
  • Hamilton RG; Hovanec-Burns D; Bourcier K; Lack G; Francis JN; Aalberse RC; Durham SR; Seyfert-Margolis V; et alT Immune Tolerance Network Grp. Allergen-specific IgG and IgG4 autoanalyzer performance and utility in assessing immunotherapy (IT) study specimens. 64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology. 121:S170-S171. (Feb 2008).
  • Radulovic S; Calderon MA; Wilson DR; Durham SR. Cochrane systematic review: Safety profile of sublingual immunotherapy (SLIT) for allergic rhinitis (AR). 64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 14 Mar 2008 - 18 Mar 2008. 121:S142-S142. MOSBY-ELSEVIER (1 Feb 2008). Author weblink DOI.
  • Shamji MH; Barkans JR; Francis JN; Kimber I; Durham SR. Confocal imaging of low affinity IgE receptor distribution on B cells: Effects of grass pollen immunotherapy. 64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology. 121:S141-S141. (Feb 2008).
  • Penagos M; Calderon M; Durham SR. Dose effect of sublingual immunotherapy in the treatment of respiratory allergic diseases. Systematic review and meta-regression of randomized clinical trials, double-blind, placebo-controlled. 64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology. 121:S125-S125. (Feb 2008).
  • Nouri-Aria KT; Jacobson MR; Furukido K; Lee D; Banfield G; Durham SR. Increases in plasmacytoid but not Myeloid Dendritic Cells (DCs) parallel the time course of allergen-induced cutaneous late responses. 64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology. 121:S11-S11. (Feb 2008).
  • Emminger W; Dahl R; Kapp A; Colombo G; Rak S; Broge L; Durham S. Long-term efficacy and safety of a grass allergen tablet for sublingual immunotherapy: Findings from a 3-yr clinical trial. 64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 14 Mar 2008 - 18 Mar 2008. 121:S75-S75. MOSBY-ELSEVIER (1 Feb 2008). Author weblink DOI.
  • Durham SR. MECHANISMS OF IMMUNOTHERAPY. 7th Symposium on Specific Allergy (SOSA), 24 Apr 2008 - 26 Apr 2008. 44:93-94. PROUS SCIENCE, SA (1 Jan 2008). Author weblink.
  • Durham SR; Penagos M. Sublingual Immunotherapy for Allergic Rhinitis in Adults and Children: Lessons from the "Big Trials"?. 19th World Congress of Asthma, 5 Nov 2008 - 8 Nov 2008. 23-31. MEDIMOND S R L (1 Jan 2008).
  • Penagos M; Calderon MA; Durham SR. Allergen-specific immunotherapy for respiratory allergy: a comprehensive database of randomized controlled trials. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology. 37:1879-1879. (Dec 2007).
  • Radulovic S; Nouri-Aria KT; Jacobson MR; Durham SR. Foxp3(+) CD4(+) CD25(+) T regulatory cells in the nasal mucosa: Influence of grass pollen immunotherapy. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology, 2 Jul 2007 - 4 Jul 2007. 37:1883-1883. BLACKWELL PUBLISHING (1 Dec 2007). Author weblink.
  • Francis JN; Varga EM; Wong C; Zach MS; Aberer W; Durham SR. Investigation of serum inhibitory activity after bee venom immunotherapy. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology. 37:1885-1885. (Dec 2007).
  • Macedo P; Campbell D; Durham SR; Chung KF; Menzies-Gow A. Prednisolone pharmacokinetics in severe asthmatics: Delayed absorption and failure to suppress endogenous cortisol. Winter Meeting of the British-Thoracic-Society. 62:A96-A97. (Dec 2007).
  • Lombardi C; Penagos M; Calderon M; Griffiths E; McLeod B; Durham SR. The search engine as a diagnostic tool in complex immunological and allergic case reports: is Google useful?. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology. 37:1878-1879. (Dec 2007).
  • Shamji MH; Barkans J; Kimber I; Francis JN; Durham SR. Visualising the inhibitory effect of blocking antibodies in grass pollen immunotherapy using confocal microscopy. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology. 37:1884-1884. (Dec 2007).
  • Skypala I; Calderon M; Leeds A; Durham S. Can symptoms or skin prick wheal size predict the outcome of food challenge with apple?. 26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology, 9 Jun 2007 - 13 Jun 2007. 62:147-147. BLACKWELL PUBLISHING (1 Jun 2007). Author weblink.
  • Nouri-Aria K; Radulovic S; Jacobson M; Durham S. FOXP3+CD4+CD25+T regulatory cells in the nasal mucosa: influence of grass pollen immunotherapy. 26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology. 62:72-73. (Jun 2007).
  • Rak S; de Monchy J; Emminger W; Durham S; Kapp A; Colombo G; Riis B; Dahl R. Grass tablet immunotherapy consistently relieves seasonal eye and nasal symptoms (including blocked nose) in consecutive seasons. 26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology, 9 Jun 2007 - 13 Jun 2007. 62:237-237. BLACKWELL PUBLISHING (1 Jun 2007). Author weblink.
  • Varga E; Zach M; Klunker S; Aberer W; Durham S; Francis J. Inhibition of facilitated antigen presentation by venom immunotherapy in children. 26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology. 62:73-74. (Jun 2007).
  • Skypala I; Calderon M; Leeds A; Durham S. Pollen-food syndrome in United Kingdom subjects - which aeroallergens are commonly involved?. 26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology, 9 Jun 2007 - 13 Jun 2007. 62:358-358. BLACKWELL PUBLISHING (1 Jun 2007). Author weblink.
  • Emminger W; Dahl R; Kappp A; Colombo G; de Monchy J; Rak S; Riis B; Durham S. Progressive effect of grass tablet immunotherapy during long-term treatment in patients with rhinoconjunctivitis. 26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology. 62:240-240. (Jun 2007).
  • Kapp A; Rak S; de Monchy J; Emminger W; Colombo G; Dahl R; Gronager P; Henmar H; et alDurham S. Sublingual grass tablet immunotherapy shows a progressive immunological effect. 26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology, 9 Jun 2007 - 13 Jun 2007. 62:238-238. BLACKWELL PUBLISHING (1 Jun 2007). Author weblink.
  • Radulovic S; Calderon M; Wilson S; Durham S. Sublingual immunotherapy for allergic rhinitis: An updated Cochrane systematic review and meta-analysis. 26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology. 62:263-263. (Jun 2007).
  • James F; Saggar L; Klunker S; Seyfert-Margolis V; Asare A; Casale T; Durham S. The combination of anti-IgE monoclonal antibody (omalizumab) with ragweed immunotherapy results in enhanced and long-term inhibitory effects on facilitated-antigen presentation. 26th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology, 9 Jun 2007 - 13 Jun 2007. 62:61-61. BLACKWELL PUBLISHING (1 Jun 2007). Author weblink.
  • Francis JN; Durham SR. Depletion of CCR4+ T cells from allergen-stimulated PBMC cultures reduces Th2 cytokine production. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology, 10 Jul 2006 - 12 Jul 2006. 36:1202-1203. BLACKWELL PUBLISHING (1 Sep 2006). Author weblink.
  • Wilcock LK; Francis JN; Paraskevopolous G; Till SJ; Durham SR. Induction and maintenance of regulatory humoral responses during grass pollen immunotherapy. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology. 36:1205-1205. (Sep 2006).
  • Martins SC; Nouri-Aria KT; Banfield GK; Jacobson MR; Watanabe H; Radulovic S; Robinson DS; Lloyd CM; et alDurham SR. Allergen-induced late cutaneous responses are associated with elevated CD3(+)CCR4(+) cells and no change in CD3(+)CCR3(+) or CD3(+)CCR8(+) cells. 62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology. 117:S282-S282. (Feb 2006).
  • Klunker S; Francis JN; Casale TB; Durham SR. Anti-IgE therapy inhibits IgE-facilitated allergen presentation and increases the efficacy of ragweed immunotherapy. 62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 3 Mar 2006 - 7 Mar 2006. 117:S89-S89. MOSBY, INC (1 Feb 2006). Author weblink DOI.
  • Wilcock LK; Francis JN; Paraskavopoulos G; Till SJ; Durham SR. Induction of IL-10 occurs early and precedes serum IgG blocking activity during a cluster regimen of grass pollen immunotherapy. 62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 3 Mar 2006 - 7 Mar 2006. 117:S330-S330. MOSBY, INC (1 Feb 2006). Author weblink DOI.
  • Dahl R; Kapp A; Ribel M; Durham SR. Longitudinal study of sublingual immunotherapy with SQ standardized grass allergen tablet - Interim safety results. 62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 3 Mar 2006 - 7 Mar 2006. 117:S220-S221. MOSBY, INC (1 Feb 2006). Author weblink DOI.
  • Krishna T; Frew A; Durham S. Quality of life in specific immunotherapy with Alutard Sq (R) grass pollen in allergic rhinoconjuntivitis - The Ukis-study results. 62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology, 3 Mar 2006 - 7 Mar 2006. 117:S326-S326. MOSBY, INC (1 Feb 2006). Author weblink DOI.
  • Shamji MH; Wilcock LK; Larche M; Francis JN; Durham SR. Validation of a functional assay of IgE-facilitated CD23-dependent allergen binding to B cells to monitor clinical efficacy of immunotherapy. 62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology. 117:S330-S330. (Feb 2006).
  • Furukido K; Banfield GK; Nouri-Aria KT; Watanabe H; Matins SC; Lloyd CM; Robinson DS; Durham SR. Allergen-induced late nasal responses are associated with an increase in CCR4 (mRNA & protein) expression in atopic subjects. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology. 35:1412-1412. (Oct 2005).
  • Shamji M; Wilcock L; Larche M; Durham S; Francis J. Analytical validation of a novel flow cytometric-based Facilitated Allergen Presentation (FAP) assay as a tool for monitoring allergen-specific immunotherapy. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology, 18 Jul 2005 - 20 Jul 2005. 35:1415-1415. BLACKWELL PUBLISHING (1 Oct 2005). Author weblink.
  • Martins SC; Banfield GK; Watanabe H; Nouri-Aria KT; Furukido K; Lloyd CM; Robinson DS; Durham SR. CCR4 and CXCR3 on CD3(+) cells in the skin following allergen and PPD challenge in atopics and non-atopic individuals. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology, 18 Jul 2005 - 20 Jul 2005. 35:1410-1411. BLACKWELL PUBLISHING (1 Oct 2005). Author weblink.
  • Calderon MA; Durham SR. Grass allergen tablets for sublingual immunotherapy in seasonal allergic rhinitis (SAR). Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology. 35:1415-1416. (Oct 2005).
  • Klunker S; Francis JN; Durham SR. Ragweed immunotherapy serum inhibits facilitated allergen presentation. Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology, 18 Jul 2005 - 20 Jul 2005. 35:1415-1415. BLACKWELL PUBLISHING (1 Oct 2005). Author weblink.
  • Skypala IJ; Cholet A; Leeds A; Durham SR. The effectiveness of clinical history as a diagnostic tool for oral allergy syndrome (OAS). Annual Meeting of the British-Society-for-Allergy-and-Clinical-Immunology. 35:1415-1415. (Oct 2005).
  • Francis J; Wilcock L; Puggioni F; Durham S. Adjuvants in allergy immunotherapy; comparison of in vitro responses to old and new adjuvants. Annual Conference of the British-Society-for-Allergy-and-Clinical-Immunology, 12 Jul 2004 - 14 Jul 2004. 34:1810-1810. BLACKWELL PUBLISHING LTD (1 Nov 2004). Author weblink.
  • Nouri-Aria KT; Pilette C; Jacobson MR; Durham SR. Seasonal increases in interleukin-9 expression and c-Kit(+) mast cells in the nasal mucosa are inhibited by grass pollen immunotherapy. Annual Conference of the British-Society-for-Allergy-and-Clinical-Immunology, 12 Jul 2004 - 14 Jul 2004. 34:1806-1806. BLACKWELL PUBLISHING LTD (1 Nov 2004). Author weblink.
  • Pilette C; Francis J; Till S; Durham SR. The CCR4 pathway mediates allergen-induced T cell recruitment to the airway in atopic asthma. Annual Conference of the British-Society-for-Allergy-and-Clinical-Immunology. 33:1465-1465. (Oct 2003).
  • Nouri-Aria KT; Wilson DR; Durham SR. Allergen immunotherapy: Immune deviation or anergy?. 27th Symposium of the Collegium-Internationale-Allergologicum. 342-345. (2003).
  • Netuveli G; Sheikh A; Hurwitz B; Barnes M; Fletcher M; Levy M; Durham SR. Effect of ethnicity on asthma prevalence and health service utilisation in the UK: A systematic review. Winter Meeting of the British-Thoracic-Society, 4 Dec 2002 - 6 Dec 2002. 57. BRITISH MED JOURNAL PUBL GROUP (1 Dec 2002). Author weblink.
  • Francis JN; Durham SR. Allergen-induced IL-10 production by peripheral blood mononuclear cells from patients receiving grass pollen immunotherapy. 21st Congress of the European-Academy-of-Allergology-and-Clinical-Immunology. 57:51-51. (Jul 2002).
  • Durham SR; Strachan DP; Bauchau V. The prevalence and diagnosis of allergic rhinitis: a cross-sectional population-based epidemiological study in six European countries. 21st Congress of the European-Academy-of-Allergology-and-Clinical-Immunology. 57:239-240. (Jul 2002).
  • Menz G; Ying S; Durham SR; Corrigan CJ; Rohinson DS; Hamid Q; Pfister R; Humbert M; et alKay AB. Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma. International Jubilee Symposium - 30 Years with IgE, 1 Sep 1998 - 2 Sep 1998. 53:15-21. MUNKSGAARD INT PUBL LTD (1 Jan 1998). Author weblink.
  • Bentley AM; Kay AB; Durham SR. Human late asthmatic reactions. Symposium on Allergic Lung Disease. 27:71-86. (May 1997).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook